ANANDAMIDEPRO
Live / Applied — Statement of use — registration review complete (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 10 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98894871
- Mark type
- Stylized text
- Filed
- 10 Dec 2024
- Published for opposition
- 08 Apr 2025
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing anandamide; pharmaceutical preparation, namely anandamide being a dietary supplement manufactured by a proprietary process that results in anandamide being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in whole or significant part from anandamide, sold as an integral component of dietary supplements and nutritional supplements for maintaining emotional balance and mental well-being, up-regulating the release of neurotransmitters, and down-regulating pain and appetite.
Owner
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2025 — USE AMENDMENT FILED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED